Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
The BMT CTN trials address issues in hematopoietic stem cell transplantation (HSCT), thereby furthering understanding of the best possible treatment approaches. The BMT CTN is committed to including widespread transplant community participation in these trials.
There are 20 Core Clinical Centers (some of which are consortia of two or more centers) with cooperative agreements from The National Heart, Lung, and Blood Institute (NHLBI) and The National Cancer Institute (NCI) to participate in the BMT CTN. Additional affiliate centers may also participate in BMT CTN trials through subcontracts with the Data and Coordinating Center (DCC).